|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Medical Representative Respiratory (Ãæû
Ãæ³² ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
11.08 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Medical Representative Respiratory (¼¿ï
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
11.08 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Medical Representative Respiratory (¼¿ï
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
10.28 |
|
|
(ÁÖ)Ƽ¾Ø¾Ë¹ÙÀÌ¿ÀÆÕ |
Á¦¾à, ÀÇ·á±â±â ÇØ¿Ü¿µ¾÷ ´ã´ç ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
1³â¡è |
ä¿ë½Ã |
12.26 |
|
|
PSI CRO Korea |
[PSI CRO Korea] ä¿ë Á¤º¸
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.31 |
|
|
(ÁÖ)¿ïÆ®¶óºêÀÌ |
ÀÇ·á±â±â ÇÊ·¯ °æ·ÂÁ÷ ¿¬±¸¿ø ¸ðÁý
¼¿ï ¼ºµ¿±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
1³â¡è |
ä¿ë½Ã |
04.26 |
|
|
(ÁÖ)ÀÎÅعÙÀÌ¿À |
(ÁÖ)ÀÎÅعÙÀÌ¿À ±¹³»¿µ¾÷ °æ·ÂÁ÷ ä¿ë (ü¿ÜÁø´ÜºÐ¾ß)
°æ±â ¾È¾ç½Ã µ¿¾È±¸, ¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
04.01 |
|
|
(ÁÖ)»çÀ̳ؽº |
ÀÇ·á±â±â ÀÓ»ó CRA (°æ·Â) ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
12.28 |
|
|
Novotech |
Pharmacovigilance Associate (Snr)_Korean Speaker Only
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
1³â¡è |
ä¿ë½Ã |
03.13 |
|
|
Á¦À̾¾¸ÞµðÆÊ |
Á¤Çü¿Ü°ú ¿µ¾÷ °æ·Â»ç¿ø ¸ðÁý
°æ±â ºÎõ½Ã ¿ø¹Ì±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
07.19 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] Clinical Data Analyst II ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
1³â¡è |
»ó½Ãä¿ë |
06.14 |
|
|
Á¦³ë¸¶ÀÎ(ÁÖ) |
Á¦³ë¸¶ÀÎ(ÁÖ) ±â°£Á¦ °æ¸®»ç¹«¿ø ¸ðÁý
°æºÏ Æ÷Ç׽à ³²±¸ | Çз¹«°ü |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
1³â¡è |
ä¿ë½Ã |
02.16 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - CRA II Opp
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.03 |
|
|
EIS CORPORATION |
¶ó¹Ì³ª¸®¾Æ Á¦Á¶ ¹× »ý»ê À¯°æÇèÀÚ ¸ðÁý
ÀÎõ ºÎÆò±¸ | Çз¹«°ü |
»ý»ê/»ý»ê°ü¸® |
1³â¡è |
»ó½Ãä¿ë |
09.10 |
|
|
ÇÑ°á¸ÞµðÄ® |
Á¤Çü¿Ü°ú ¿µ¾÷,¿µ¾÷°ü¸®
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
°ø°³Ã¤¿ë |
1³â¡è |
ä¿ë½Ã |
09.16 |
|